Relationship between serum cytokine and growth factor concentrations and coronary artery disease

Clinical Biochemistry

Volumn 48, Issue 9, 2015, Pages 575-580

  Mirhafez, Seyed Reza ^a,b   Zarifian, Ahmadreza ^c   Ebrahimi, Mahmoud ^a   Ali, Ramin Fakhre Ale ^c   Avan, Amir ^c   Tajfard, Mohammad ^d   Mohebati, Mohsen ^a   Eslami, Saeid ^c   Rahsepar, Amir Ali ^a   Rahimi, Hamid Reza ^c   Mehrad Majd, Hassan ^b   Ferns, Gordon A ^e   Ghayour Mobarhan, Majid ^a,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NEYSHABUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Coronary artery diseases; Cytokines; Growth factors; Inflammation

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GLUCOSE; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; SIGNAL PEPTIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; ANGIOGRAPHY; BLOOD; MIDDLE AGED; RADIOGRAPHY;

AGED; ANGIOGRAPHY; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED;

EID: 84929965588     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.02.002     Document Type: Article

References (39)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2012 update a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
2. Lewis S.L., Dirksen S.R., Heitkemper M.M., Bucher L. Medical-surgical nursing: assessment and management of clinical problems, single volume 2013, Elsevier Health Sciences, [978-0323065818].
3. Rajappa M., Sen S.K., Sharma A. Role of pro-/anti-inflammatory cytokines and their correlation with established risk factors in South Indians with coronary artery disease. Angiology 2009, 60(4):419-426.
4. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008, 28(11):1897-1908.
5. Calle M.C. Inflammatory Markers are Modulated by Diet in Latinos with Type 2 Diabetes and by Resistance Exercise in a Healthy Population: Doctoral Dissertations. Paper AAI3464346 2011.
6. George S.J., Johnson J. Atherosclerosis: molecular and cellular mechanisms 2010, John Wiley & Sons, [978-3-527-32448-4].
7. Martins T.B., Anderson J.L., Muhlestein J.B., Horne B.D., Carlquist J.F., Roberts W.L., et al. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am J Clin Pathol 2006, 125(6):906-913.
8. Tousoulis D., Antoniades C., Koumallos N., Stefanadis C. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev 2006, 17:225-233.
9. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352(16):1685-1695.
10. Zakynthinos E., Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009, 53(3):317-333.
11. Zenti M.G., Stefanutti C. Effects of selective H.E.L.P. LDL-apheresis on plasma inflammatory markers concentration in severe dyslipidemia: implication for anti-inflammatory response. Cytokine 2011, 56(3):850-854.
12. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004, 351(25):2599-2610.
13. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101(15):1767-1772.
14. Szodoray P., Timar O., Veres K., Der H., Szomjak E., Lakos G., et al. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines-immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol 2006, 64(3):336-344.
15. Boisvert W.A., Curtiss L.K., Terkeltaub R.A. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 2000, 21(2-3):129-137.
16. Charo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 2004, 95(9):858-866.
17. Reape T.J., Groot P.H. Chemokines and atherosclerosis. Atherosclerosis 1999, 147:213-225.
18. Mocellin S., Panelli M.C., Wang E., Nagorsen D., Marincola F.M. The dual role of IL-10. Trends Immunol 2003, 24(1):36-43.
19. Goswami B., Rajappa M., Mallika V., Shukla D.K., Kumar S. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction. Clin Chim Acta 2009, 408(1-2):14-18.
20. Martinovic I., Abegunewardene N., Seul M., Vosseler M., Horstick G., Buerke M., et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 2005, 69(12):1484-1489.
21. Lamb D.J., Modjtahedi H., Plant N.J., Ferns G.A. EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis 2004, 176(1):21-26.
22. Mattson M.P., Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 2005, 16(3):129-137.
23. Rihal C.S., Raco D.L., Gersh B.J., Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 2003, 108(20):2439-2445.
24. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360(10):961-972.
25. Scanlon P.J., Faxon D.P., Audet A.-M., Carabello B., Dehmer G.J., Eagle K.A., et al. ACC/AHA guidelines for coronary angiography123: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999, 33(6):1756-1824.
26. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004, 110(14):e340-e437.
27. Kazemi-Bajestani S.M., Ghayour-Mobarhan M., Ebrahimi M., Moohebati M., Esmaeili H.A., Ferns G.A. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease. Clin Lab 2007, 53(1-2):49-56.
28. FitzGerald S.P., Lamont J.V., McConnell R.I., Benchikh E.O. Development of a high-throughput automated analyzer using biochip array technology. Clin Chem 2005, 51(7):1165-1176.
29. Molloy R.M., Mc Connell R.I., Lamont J.V., FitzGerald S.P. Automation of biochip array technology for quality results. Clin Chem Lab Med 2005, 43(12):1303-1313.
30. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., Janowska J., Szulc A., Jastrzebska-Maj E., et al. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis 2003, 14(6):431-438.
31. Danesh J., Kaptoge S., Mann A.G., Sarwar N., Wood A., Angleman S.B., et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008, 5(4):e78.
32. Hashmi S., Zeng Q.T. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 2006, 17(8):699-706.
33. Luc G., Bard J.-M., Juhan-Vague I., Ferrieres J., Evans A., Amouyel P., et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease The PRIME study. Arterioscler Thromb Vasc Biol 2003, 23(7):1255-1261.
34. Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999, 100(8):793-798.
35. Boekholdt S.M., Peters R.J., Hack C.E., Day N.E., Luben R., Bingham S.A., et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004, 24(8):1503-1508.
36. Mallat Z., Corbaz A., Scoazec A., Besnard S., Lesèche G., Chvatchko Y., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001, 104(14):1598-1603.
37. Hoffman M., Blum A., Baruch R., Kaplan E., Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004, 172(1):1-6.
38. Hojo Y., Ikeda U., Takahashi M., Shimada K. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002, 161(2):403-408.
39. Eaton C.B., Gramling R., Parker D.R., Roberts M.B., Lu B., Ridker P.M. Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England. Atherosclerosis 2008, 200(1):221-227.